The global food system is increasingly under pressure as rising demand for the most resource-intensive products—meat and dairy—coincides with crop stress and extreme weather events associated with climate change. Emerging technologies to produce high-quality proteins from non-animal sources such as plants, microbes, fungi, and cell culture are gaining market share to address the demand gap. These production platforms also offer increased resilience and reduced vulnerability to global shocks like animal disease outbreaks, such as the H5N1 bird flu outbreak that is currently decimating global poultry and egg supplies. However, there remain technological, scaling, and manufacturing challenges that must be overcome for these alternative protein sources to become more widely available and affordable. There is also a nuanced landscape of consumer sentiment, incumbent industry pressure, and political will to navigate within the transition toward more sustainable and resilient protein production systems. Within the context of a highly globalized agricultural system, there is also the potential for substantial food security and national security risks that may arise for countries that do not orient themselves to be on the leading edge of this protein transition. This session will explore the opportunities and challenges that will arise along the way.
Until recently, biomanufacturing was mostly seen as an environmentally friendly way to produce materials, ingredients, or medicines as an alternative to petrochemical processing or synthetic chemistry. However, recent and anticipated changes in the global geopolitical landscape – with substantial implications for trade relationships and global supply chains – make clear that fostering a robust domestic biomanufacturing sector is quickly becoming a strategic imperative. A long-awaited transition toward a bioeconomy is poised to become reality as countries increasingly seek to establish supply chain independence and resilience, as well as access to higher-performing materials, ingredients, and other capabilities through AI-powered molecular design. This session will examine biomanufacturing's potential across multiple sectors, with a particular lens on defense applications as a case study to examine several leading-edge indicators of wider adoption of bioproduction. Defense use of novel technologies often serves as a harbinger of larger societal and technological shifts that will ripple out across other domains because of its relative risk tolerance, cost tolerance, and ability to pre-empt evolving threats that may ultimately impact the private sector.
Food and agriculture serve as proving grounds for biotechnological advances from multiple perspectives. This sector is often where new technologies are first deployed and made visible to consumers, due to lower regulatory barriers relative to most biomedical applications, thus providing a barometer for consumer receptivity and sentiment to novel techniques. In addition, food and agriculture represent larger-volume, lower-cost markets for biotechnology solutions relative to the biomedical or precision materials applications in which they are often first developed and deployed. Therefore, food and agriculture require scaling and cost reduction innovations beyond what is tolerated in other sectors, and which pave the way for even higher-volume and lower-cost applications in industrial chemistry, fuels, and more. Thus, this sector can serve as a harbinger of larger societal and biotechnological shifts that will ripple out across all other domains. This session will examine historical trends of technology diffusion into and beyond food and agriculture, as well as delve into emerging technologies within the alternative protein field as a case study to examine several leading-edge indicators of wider adoption of recent biotechnological advances in food technology and beyond.